Our Advantages

Experience & Expertise

Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe.

Flexible Collaboration Model

We support flexible collaboration models that fit different projects to meet diversified customer needs. In projects with limited budget, upon request, we take on more roles throughout the project life cycle.

Quality Management

GenScript ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility.

Capabilities & Capacity

Current capacity: up to 20 GCT IND and 400 L biologics.

Total 16,800 L bioreactors by 2023.

News & Activities

News 2021-09-29

GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South KoreaLearn More »

News 2021-08-11

GenScript ProBio and TG ImmunoPharma Enter into Collaboration on Innovative Antibody Drug Project Learn More »

News 2021-06-02

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement Learn More »

News 2021-06-01

GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIIILearn More »

All News »

About ProBio


Subscribe to receive updates & promotions from GenScript ProBio!

* We'll never share your email address with any third parties.